论文部分内容阅读
目的:观察米非司酮联合依沙吖啶用于瘢痕子宫孕中期引产的临床效果。方法:选择医院2014年1月至2014年12月收治的瘢痕子宫孕中期引产患者74例,随机分为实验组和对照组,各37例,对照组患者经羊膜腔注入依沙吖啶,实验组患者在对照组基础上服用米非司酮,观察两组患者引产成功情况及患者用药后引产情况。结果:两组患者引产成功率比较差异无统计学意义(P>0.05);实验组患者各项引产指标数值均低于对照组(P<0.05)。结论:临床采用米非司酮联合依沙吖啶终止瘢痕子宫中期妊娠患者时,具有良好的临床效果。
Objective: To observe the clinical effect of mifepristone combined with ethacridine in the induction of labor during the second trimester of scar pregnancy. Methods: Seventy-four patients with induced abortion in the second trimester of pregnancy from January 2014 to December 2014 were randomly divided into experimental group and control group, 37 cases in each group. In the control group, ethacridine was injected into the amniotic cavity, The patients in the control group took mifepristone on the basis of the control group, and observed the successful induction of labor and the induced abortion in the two groups. Results: There was no significant difference in the successful rate of induction of labor between the two groups (P> 0.05). The index of induced labor in the experimental group was lower than that of the control group (P <0.05). Conclusion: The clinical use of mifepristone combined with ethacridine termination of uterine scar pregnancy in patients with a good clinical effect.